Skip to content
lsd.com

Indication

Hallucinogens

2 registered trials testing Psilocybin for this indication, none currently recruiting.

2
Registered trials
0
Recruiting
0
In Phase 3

Stay told

When a new trial opens

Research alerts

Get a notification when a trial for Hallucinogens trials starts recruiting

This registry is rebuilt every day. If no trial is recruiting for you today, that can change within weeks.

This form sends your email address and the topic of this page to Brevo, our email provider, which stores them on servers in the European Union. We never sell that address, never share it with anyone, and never use it for advertising. One email deletes it. What is held, and where.

Trials

All 2 trials for Hallucinogens

TrialStatusPhaseSubstanceSites
Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term MeditatorsNCT01988311 · Johns Hopkins UniversityCompletedPhase 1psilocybin1
Effect of Psilocybin on the Positive Valence System in Treatment-resistant DepressionNCT06650800 · Centre Hospitalier Universitaire de NīmesCompletedNot applicablepsilocybin1

Records from ClinicalTrials.gov API v2, data build 2026-08-25. Indications are the sponsors’ own words. LSD.com reports registered clinical research. It is not medical advice, it is not a recommendation to take any substance, and trial listings are not endorsements. Talk to a clinician.